(Q38113457)

29 August 2017

title

Biomarkers for incident CKD: a new framework for interpreting the literature (English)

1 reference

29 August 2017

0 references

1

Michael G Shlipak

1 reference

29 August 2017

Erica C Day

2

1 reference

29 August 2017

language of work or name

English

0 references

publication date

11 June 2013

1 reference

Nature Reviews Nephrology

29 August 2017

published in

1 reference

29 August 2017

volume

9

1 reference

29 August 2017

issue

8

1 reference

29 August 2017

page(s)

478-483

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2013.108

29 August 2017

exact match

0 references

cites work

Biomarkers of cardiovascular disease: molecular basis and practical considerations

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Prevalence of chronic kidney disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Statistical methods for assessment of added usefulness of new biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Interpreting incremental value of markers added to risk prediction models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Comments on ‘Integrated discrimination and net reclassification improvements—Practical advice’

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Problems with risk reclassification methods for evaluating prediction models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Assessing the value of risk predictions by using risk stratification tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

New loci associated with kidney function and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Population-based risk assessment of APOL1 on renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Low birth weight is associated with chronic kidney disease only in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Chronic kidney disease associated with environmental toxins and exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Environmental Lead Exposure and Chronic Renal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Clinical and subclinical cardiovascular disease and kidney function decline in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Uromodulin levels associate with a common UMOD variant and risk for incident CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Urinary monocyte chemotactic protein-1 and transforming growth factor-β in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

A multi-marker approach to predict incident CKD and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Low birthweight and chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.108

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23752888

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23752888

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEPH.2013.108

1 reference

29 August 2017

1 reference